|
|||||
|
|
Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole |
|
| Authors: | Timothy L. Jackson Thomas Verstraeten Luc Duchateau Benedicte Lescrauwaet |
| Affiliation: | 1. School of Medicine, King's College London, London, UK;2. P95 Pharmacovigilance and Epidemiology Services, Leuven, Belgium;3. Ghent University, Ghent, Belgium;4. Xintera Ltd, Cambridge, UK |
| Abstract: | |
| Keywords: | macular hole minimal clinically important difference ocriplasmin principal components analysis symptomatic vitreomacular adhesion/vitreomacular traction VFQ‐25 |